Skip to main content

Molecular Data Inc. Announces Pricing of Initial Public Offering

SHANGHAI, China, Dec. 30, 2019 (GLOBE NEWSWIRE) — Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that it has priced its initial public offering of 11,500,000 American depositary shares (“ADSs”) at a price to the public of US$5.38 per ADS for a total offering size of approximately US$61.87 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs. Each ADS represents three Class A ordinary shares of the Company. The ADSs are expected to begin trading on the Nasdaq Stock Market today under the ticker symbol “MKD.”
The Company has granted to the underwriters an option, exercisable within 30 days from the date of the final prospectus, to purchase up to an aggregate of 1,725,000 additional ADSs at the initial public offering price per ADS.AMTD Global Markets Limited, Fosun Hani Securities Limited and Boustead Securities, LLC are acting as the representatives of the underwriters jointly.A registration statement related to these securities has been filed with, and declared effective by, the United States Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Past performance is not indicative of future results. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of total loss.This offering is being made only by means of a prospectus forming part of the effective registration statement. A copy of the final prospectus relating to the offering may be obtained, when available, by contacting the following underwriters: (1) AMTD Global Markets Limited, Address: 23/F – 25/F Nexxus Building, 41 Connaught Road Central, Hong Kong, by telephone at +852-3163-3288, or via email: prospectus@amtdgroup.com; (2) Fosun Hani Securities Limited, Address: Suite 2101 – 2105, 21/F, Champion Tower, 3 Garden Road, Central, Hong Kong, by telephone at +852-2869-1318, or by emailing: project.magic@fosunhani.com; (3) Boustead Securities, LLC, Address: 6 Venture, Suite 395, Irvine, CA 92618, USA, by telephone at +1-949-502-4408 or by emailing offerings@boustead1828.com.About Molecular Data Inc.Molecular Data Inc. is a leading technology-driven platform in China’s chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company’s e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data Weixin account, Chemical Community App and other ancillary platforms.For investor and media inquiries, please contact:In China:Molecular Data Inc.
Investor Relations
Tel: +86-400-6021-666
E-mail: Investor@molbase.com
The Piacente Group, Inc.
Emilie Wu
Tel: +86-21-6039-8363
E-mail: molbase@tpg-ir.com
In the United States:The Piacente Group, Inc. 
Brandi Piacente
Tel: +1-212-481-2050
E-mail: molbase@tpg-ir.com
Source: Molbase

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.